Prednisolone/zoledronic acid

Drug Profile

Prednisolone/zoledronic acid

Alternative Names: VOLT-01

Latest Information Update: 11 Apr 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Levolta Pharmaceuticals
  • Developer Levolta Pharmaceuticals; Menzies Research Institute Tasmania
  • Class Anti-inflammatories; Bisphosphonates; Calcium regulators; Corticosteroids; Drug conjugates; Glucocorticoids; Imidazoles; Osteoporosis therapies; Pregnadienetriols; Small molecules
  • Mechanism of Action Bone resorption factor inhibitors; Glucocorticoid receptor agonists; HMG-CoA reductase inhibitors; Osteoclast inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase III Osteoarthritis

Most Recent Events

  • 11 Apr 2017 Phase-III development for Osteoarthritis of the knee is ongoing in Australia (IV)
  • 28 Dec 2016 Levolta Pharmaceuticals completes a phase II trial in Osteoarthritis in Australia (IV) before December 2016 (Levolta Pharmaceuticals pipeline)
  • 18 Nov 2014 Efficacy & adverse events data from a phase II trial in Osteoarthritis presented at the Annual Meeting of the American College of Rheumatology (ACR-2014)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top